Get startedLog in
    Picture of Alembic Pharmaceuticals logo

    APLLTD — Alembic Pharmaceuticals News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareBalancedMid CapHigh Flyer
    All News

    Brief: Alembic Pharmaceuticals Says FDA Issues Warning Letter For Bioequivalence Study; No Operational Restrictions Imposed

    Picture of Alembic Pharmaceuticals logoAlembic Pharmaceuticals
    13/07/2026 14:35
    BRIEF-Alembic Pharmaceuticals Says FDA Issues Warning Letter For Bioequivalence Study; No Operational Restrictions Imposed
    July 13 (Reuters) - Alembic Pharmaceuticals Ltd ALEM.NS:
    • ALEMBIC PHARMACEUTICALS - USFDA ISSUES WARNING LETTER DATED JULY 10, 2026 FOR BIOEQUIVALENCE STUDY
    • ALEMBIC PHARMACEUTICALS - NO OPERATIONAL RESTRICTIONS IMPOSED ON BIOEQUIVALENCE FACILITY
    • ALEMBIC PHARMACEUTICALS - WARNING LETTER TO CLINICAL INVESTIGATOR ASSOCIATED WITH BIOEQUIVALENCE STUDY CONDUCTED AT CO'S BIOEQUIVALENCE FACILITY
    Source text: ID:nBSE5Dy76k
    Further company coverage: ALEM.NS

     ((Reuters.Briefs@thomsonreuters.com;;))

    Recent news on Alembic Pharmaceuticals

    See all news